Join Dr. Milena Milutinovic from Quanterix and Dr. Nicholas Ashton from the University of Gothenburg for a webinar highlighting the role of Simoa® technology in the identification and validation of novel biomarkers. Learn about the potential of this technology to transform the drug approval process and patient management. Dr. Ashton will also review the gaps in blood biomarker research and share how his work is addressing this need. The discussion will then demonstrate how Simoa® technology is advancing neurological research and the clinical utility of blood-based biomarkers.

ACCESS RECORDING